Moderna Vaccine Significantly More Effective Against Delta Variant Than Pfizer
medrxiv.org
medrxiv.org
Moderna and Pfizer both have comparable (low) risk of hospitalization and death when infected with delta variant.
Primary difference vaccines is dosage (Moderna had a bit over 3x amount of material per shot) and maybe scheduling (Pfizer was scheduled for 21 days between shots, Moderna for 28 - though given how shots were actually administered in reality, this is probably a wash).
Study design has many limitations, but is probably reasonably generalizable.
As a Canadian with combo Pfizer+Moderna, I am personally curious what my risk profile would look like. I wonder if a similar study on Canadian data could be useful - an intermediate risk profile for the combo shot would sure be persuasive evidence.
Edit: Removed ambiguity in second sentence.
This is still probably the most important overall point.
There's currently a study underway in the UK (I forget the name, but it run by the University of Oxford) to assess the efficacy of mixed-dose vaccination.
Some of the older (55+) crowd got a different mixture, with AstraZeneca shots in the early spring and Pfizer early summer.
Say what you will about our weird combos, but we have a very high number of people immunized now, so it seems to be working...
Mixed Oxford/Pfizer vaccine schedules generate robust immune response against COVID-19, finds Oxford-led study: https://www.ox.ac.uk/news/2021-06-28-mixed-oxfordpfizer-vacc... ,
.. https://science.sciencemag.org/content/373/6553/397 - "the ideal vaccination strategy may use an intramuscular vaccine to elicit a long-lived systemic IgG response and a broad repertoire of central memory B and T cells, followed by an intranasal booster that recruits memory B and T cells to the nasal passages and further guides their differentiation toward mucosal protection, including IgA secretion and tissue-resident memory cells in the respiratory tract." .. (https://news.ycombinator.com/item?id=28019151),
https://news.ycombinator.com/item?id=28016821 - Covid-19 Vaccine Intranasal Study (COV008), UK phase 1 trial recruiting,
That said, current vaccines don't provoke the exact same response as an actual infection, particularly in that they don't fully stimulate an immune response in the mucous membranes of the upper repository tract. Here's an Scientific American round-up article (from back in March): https://www.scientificamerican.com/article/to-beat-covid-we-...
[..]
The current vaccines are excellent at helping the body stop the virus as it progresses into the lungs and further (thus the massive reduction in severe illness and deaths). But it still means that there's a period of a few days after initial infection when a vaccinated person has a relatively naive immune response (while the virus is mostly just in the nose/throat). This would then result in the person still being pretty contagious. (https://news.ycombinator.com/item?id=28014448).
I would like to see intranasal Novavax (intranasal mRNA is more difficult ?), having good results, as an option to this mix..
You mean if you then get the delta variant? Or low risk of hospitalization and death by simply getting the shot?
I understood there are studies that say a longer delay may be better, so I'd be curious too how the result here translates to people who had a much longer time between shots. Was the UK also in this situation?
https://globalnews.ca/news/8021692/mixing-covid-19-vaccines-...
It seems like Pfizer had more opportunties go wrong especially when rollout was outside of hospital settings and at population scale. My understanding was initially Pfizer was limited to hospitals in Canada, but ended up in pharmacies and other temporary sites.
To be fair, you would have a low chance without any vaccinations as well. I think in the lower age brackets the risk reduction was < 10%, which is perhaps even in the range of statistical fluctuations even with large sample groups.
At least the data I saw last, cannot find it currently.
Researchers have yet to determine how long natural immunity lasts, and it may last for a very long time. Immunity from vaccines is expected to be at least as durable as natural immunity, though some studies have shown a slight decline in protection over months. But there are definitely no clear signs yet that an annual shot will be necessary.
Meanwhile, Biontech (the developer of the Pfizer vaccine) applied in Europe for approval to administer third shots 6 to 8 month after the second shot. It remains to be seen, whether the higher concentrated Moderna shots will need a third one a bit later.
One has to be very careful to properly separate a lot of different aspects for drawing general conclusions, regarding this pandemic.
The preliminary results looked great. Combined with low rate of side-effects and higher storage temp (2-8 C), it could have been a good 2nd (or 3rd) choice for the developing world.
https://www.nih.gov/news-events/news-releases/us-clinical-tr...
Basically, there are still more questions than answers in my mind. I just hope the national countermeasure compensation fund will be able to handle any potential fallout.
So it's mostly a concern that in one way we are targeting a spike protein on out own cell, but normally a virus would be complete and not be displayed as part of the cell wall. That's where I wonder if some people's immune system might code off of other normal proteins in addition to the spike. I would have thought there would at least have been a study about autoimmune antibody levels. I found one about severe covid patients having a higher likelihood of having them, but I couldn't find a study looking at the vaccines. It's pretty frustrating that I'm being downvoted for asking what I think is a legitimate question, one that apparently hasn't been looked into (since I can't find any study and the downvoters haven't provided one either).
Every day we can get any approval sooner is so many lives saved!
For example: https://www.fda.gov/news-events/press-announcements/fda-brie...
For shelf life and storage, FDA typically very much prefers real-time rather than simulated/accelerated data. For the time interval listed here (1 month at fridge), they certainly would have done a real-time study.
I've only worked in diagnostics (and any reagents needed for that), so I don't know if the FDA would require these studies to have an actual human efficacy/safety component, or if these vaccines just passing some sort of QC test (presumably the same screen they use to manufacture) is enough.
There was focus on the requirements, but there were lots of people arguing that they weren't that onerous for wealthy countries (and they aren't particularly onerous).
I am using "just" to mean simply rather than recently. For a wealthy government willing to spend, acquiring freezers is not a problem.
https://www.medrxiv.org/content/10.1101/2021.08.06.21261707v...
I think most folks around me call their annual flu vaccine a "flu shot", but I still think it qualifies as a vaccine even though we don't think of it of the same severity as your one-time childhood vaccines.
Bloomberg: “A month after the third shot, 55% of those who got it developed antibody levels likely to provide significant protection.”
Only 5% over half were “Likely” plus “significant” which is not definite by a long shot (no pun intended)
https://www.bloomberg.com/news/articles/2021-08-11/third-mod...
If so, why?
After the immunocompromised have had the opportunity to protect themselves, the booster will be made available to all, just like the initial shots earlier this year. Those will be followed by another booster or more next year and so on.
For example,
One dose of MMR vaccine is 93% effective against measles, 78% effective against mumps, and 97% effective against rubella.
Two doses of MMR vaccine are 97% effective against measles and 88% effective against mumps. [1]
[1] https://www.cdc.gov/vaccines/vpd/mmr/public/index.html#:~:te....
The logic for a booster actually would be defense, it boosts antibodies which helps block more infections. An injection designed to modulate immune response by exposing the immune system to the target antigen is certainly a vaccine though.
Basically when you get a transplant organ, the body's immune system tries to kill it so they have to use powerful drugs to kill off the immune system.
http://mri.cts-mrp.eu/download/AT_H_0126_001_FinalPL.pdf
1st dose,
2nd dose 1 month later,
3rd dose 5 months later,
1st booster 3 years later,
additional boosters every 5 years
I think it would be great if we had effective covid vaccines with such a schedule
For example, about 33% of the American population was exposed to COVID, according to the CDC [1]
If Pfizer is 42% effective, would that effectiveness value drop even further?
[1] https://www.thedenverchannel.com/news/national/coronavirus/c...
From my vantage point, Pfizer had far fewer side effects. One acquaintance who had Moderna got walloped so bad on the first shot that they didn't get their second shot.
Of course, all anecdotes. I'd love to read some better numbers.
It was totally worth it, though, and I'd do it again! If you're on the fence - please go get your shot(s)!
As another data point, I wouldn't and don't think it was worth it. Being KO for 4 days when the virus is mundane is not a good trade. (Im 25ish). Plus it doesn't provide 100% protection so I can still get it.
https://www.statista.com/statistics/1191568/reported-deaths-...
The person describing four days of being down is not common and is an extreme case. I myself got a little tired day of, had some mild chills the night of, and was a little sore with a headache the morning after. I took some ibuprofen, drank a lot of water, and ate well, and I felt fine later in the day after. I get the feeling this is very typical.
The response to the vaccine is simply your body preparing itself. Getting the virus isn’t that and has a lot of potential for damage.
P(getting disease) * P(symptomatic | sick) * P(worse than 4 days fever | symptomatic) gets small very fast. Notwithstanding the fact that inflicting damage upon yourself is psychologically worse than chance events like getting a virus.
and yes well worth it and I'll do it again.
https://www.businessinsider.com/covid-vaccine-side-effects-d...
I got the Moderna vaccine. The second shot hit me pretty hard, I was definitely knocked down for a day. But honestly I was happy about that, being out for one day and then back to normal isn't that big of a deal, and it's a signal that the vaccine did something significant.
Non-medically educated opinion ahead: I think symptoms of illness are mostly a result of immune system activity, and so vaccine side effects are an indication that the immune system is working hard. That's the whole point of a vaccine.
The graph of Moderna cases in the linked paper looks roughly proportional to the unvaccinated cases to me, which suggests there was little to no reduction in effectiveness over that time period. In contrast, the Pfizer cases look to be growing more quickly than the unvaccinated cases, indicating a reduction in effectiveness over time.